Menu
Search
|

Menu

Close
X

Antares Pharma Inc ATRS.OQ (NASDAQ Stock Exchange Capital Market)

2.70 USD
-- (--)
As of Jul 16
chart
Previous Close 2.70
Open --
Volume --
3m Avg Volume 211,834
Today’s High --
Today’s Low --
52 Week High 4.09
52 Week Low 1.59
Shares Outstanding (mil) 156.83
Market Capitalization (mil) 360.29
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.15
Price to Sales (TTM)
vs sector
211.67
8.04
Price to Book (MRQ)
vs sector
--
4.28
Price to Cash Flow (TTM)
vs sector
--
22.37
Total Debt to Equity (MRQ)
vs sector
--
17.43
LT Debt to Equity (MRQ)
vs sector
--
13.25
Return on Investment (TTM)
vs sector
--
13.23
Return on Equity (TTM)
vs sector
--
15.27

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

SUITE 300, 100 PRINCETON SOUTH
EWING   NJ   8628

Phone: +1609.3593020

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

SPONSORED STORIES